1e
19
1
49
2
2
18
1b
1d
18
32
4a
1d
2 29
1d
25
Eric J. Brown, Ph.D.
78
4a
Associate Professor of Cancer Biology
28
55
3
65
Member, Abramson Cancer Center
71
Fellow, Institute on Aging, University of Pennsylvania SOM
60
Member, Penn Skin Disease Research Center
67
Member, Penn Institute for Regenerative Medicine
94
Member, Institute for Translational Medicine and Therapeutics, University of Pennsylvania SOM
78
Associate Investigator, Abramson Family Cancer Research Institute
77
Director of Education, Abramson Family Cancer Research Institute
11
Department: Cancer Biology
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
57
4
3
3
1d
57
Abramson Family Cancer Research Institute
24 Department of Cancer Biology
23 Perelman School of Medicine
22 University of Pennsylvania
16 514 BRB II/III
3b 421 Curie Boulevard
Philadelphia, PA 19104-6160
26
24 Department of Cancer Biology
23 Perelman School of Medicine
22 University of Pennsylvania
16 514 BRB II/III
3b 421 Curie Boulevard
Philadelphia, PA 19104-6160
2e
Office: 215-746-2805
32 Fax: 215-573-2486
24
83
32 Fax: 215-573-2486
24
Email:
brownej@upenn.edu
12
brownej@upenn.edu
18
Publications
23 a
3
2
29
23 a
Links
172 Search PubMed for articles
45 Cell and Molecular Biology graduate group faculty webpage.
77 Abramson Institute Faculty Page
c
4
b
1f
172 Search PubMed for articles
45 Cell and Molecular Biology graduate group faculty webpage.
77 Abramson Institute Faculty Page
c
13
Education:
21 9 B.A. 15 (Genetics) c
3d University of California at Berkeley, 1989.
21 a Ph.D. 17 (Immunology) c
2b Harvard University, 1996.
c
3
3
3
3
8d
Permanent link21 9 B.A. 15 (Genetics) c
3d University of California at Berkeley, 1989.
21 a Ph.D. 17 (Immunology) c
2b Harvard University, 1996.
c
2 29
21
1e
1d
24
5e
7d Mechanisms that maintain genome stability during DNA replication and their importance in cancer treatment and aging.
8
88 Key words: DNA damage checkpoints, DNA repair, ATR, CHK1, replication fork stability, genome integrity, cancer and aging.
8
26 Description of Research
8
1ee Maintaining the genome integrity delays the onset of cancer and other age-associated diseases. The processes that safeguard the genome are particularly important during DNA replication, when the normally stable DNA duplex structure is rendered susceptible to recombination events and collapse. My laboratory studies how genome integrity is maintained during DNA replication and investigates how defects in these mechanisms impact age-associated diseases, and cancer risk and treatment.
8
41c As an essential sensor of problems occurring during DNA replication, the ATR protein kinase regulates a signal transduction cascade that preserves troubled DNA replication forks and prevents their collapse into DNA double strand breaks. The conditions that activate the ATR pathway during DNA replication include oncogenic stress, replisome dysfunction, and encounters with difficult-to-replicate DNA sequences and naturally occurring forms of DNA damage. In aggregate, such problems are relatively common, particularly in cancers. Thus, ATR pathway, performs an essential function in genome maintenance that influences the emergence of cancer, cancer treatment and other age-associated diseases. Using proteomic and genomic approaches systems, we are investigating how the ATR pathway counters replicative stress at the replication fork and throughout the genome. In addition, we are investigating the use of ATR inhibitors as cancer treatments by identifying biomarkers of sensitivity as well as novel targets for combination drug treatments.
8
20 Rotation Projects
51 Please contact Dr. Brown for information on potential rotation projects.
8
1d Lab personnel
2b Muzaffer Kassab, Research Associate
2d Rahul Mandal, Postdoctoral Researcher
2e Jasmine Peake, Postdoctoral Researcher
30 Konstantinos Tsingas, Research Assistant
2b Praveen Rodrigo, Research Assistant
8
43 Heather Birmingham, Administrative Assistant, hbir@upenn.edu
26 29
27
Description of Research Expertise
2b Research Interests7d Mechanisms that maintain genome stability during DNA replication and their importance in cancer treatment and aging.
8
88 Key words: DNA damage checkpoints, DNA repair, ATR, CHK1, replication fork stability, genome integrity, cancer and aging.
8
26 Description of Research
8
1ee Maintaining the genome integrity delays the onset of cancer and other age-associated diseases. The processes that safeguard the genome are particularly important during DNA replication, when the normally stable DNA duplex structure is rendered susceptible to recombination events and collapse. My laboratory studies how genome integrity is maintained during DNA replication and investigates how defects in these mechanisms impact age-associated diseases, and cancer risk and treatment.
8
41c As an essential sensor of problems occurring during DNA replication, the ATR protein kinase regulates a signal transduction cascade that preserves troubled DNA replication forks and prevents their collapse into DNA double strand breaks. The conditions that activate the ATR pathway during DNA replication include oncogenic stress, replisome dysfunction, and encounters with difficult-to-replicate DNA sequences and naturally occurring forms of DNA damage. In aggregate, such problems are relatively common, particularly in cancers. Thus, ATR pathway, performs an essential function in genome maintenance that influences the emergence of cancer, cancer treatment and other age-associated diseases. Using proteomic and genomic approaches systems, we are investigating how the ATR pathway counters replicative stress at the replication fork and throughout the genome. In addition, we are investigating the use of ATR inhibitors as cancer treatments by identifying biomarkers of sensitivity as well as novel targets for combination drug treatments.
8
20 Rotation Projects
51 Please contact Dr. Brown for information on potential rotation projects.
8
1d Lab personnel
2b Muzaffer Kassab, Research Associate
2d Rahul Mandal, Postdoctoral Researcher
2e Jasmine Peake, Postdoctoral Researcher
30 Konstantinos Tsingas, Research Assistant
2b Praveen Rodrigo, Research Assistant
8
43 Heather Birmingham, Administrative Assistant, hbir@upenn.edu
26 29
23
12b Kim H, George E, Ragland R, Rafial S, Zhang R, Krepler C, Morgan M, Drapkin R, Brown EJ and Simpkins F: Targeting ATR/CHK1 is more effective than PARPi alone in BRCA mutant models. Clinical Cancer Research 23: 3097-3108, 2017.
ad Anastassiadis T, Brown EJ: Wild-type RAS: Keeping mutant RAS in CHK. Cancer Cell 25(2): 137-8, 2014.
110 Ragland RL, Patel S, Rivard RS, Smith K, Peters AA, Bielinsky AK, Brown EJ: RNF4 and PLK1 are required for replication fork collapse in ATR-deficient cells. Genes & Development 27(20): 2259-73, 2013.
13a Schoppy DW, Ragland RL, Gilad O, Shastri N, Peters AA, Murga M, Fernandez-Capetillo O, Diehl JA, Brown EJ: Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR. Journal of Clinical Investigation 122(1): 241-252, 2012.
175 Gilad, O., Nabet, B.L., Ragland, R.L., Schoppy, D.W., Smith, K.D., Durham, A.C., Brown, E.J: Combining ATR suppression with oncogenic Ras synergystically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner. Cancer Research 70(23): 9693-9702, 2010.
12f Ruzankina, Y., Schoppy, D.W., Asare, A., Clark, C.E., Vonderheide, R.H., Brown, E.J.: Tissue regenerative delays and synthetic lethality in adult mice upon combined deletion of ATR and p53. Nature Genetics 41(10): 1144-1149, 2009.
11a Chanoux, R.A., Yin, B., Urtishak, K.A., Bassing, C.H., Brown, E.J.: ATR and H2AX cooperate in maintaining genome stability under replication stress. The Journal of Biological Chemistry 284(9): 5994-6003, 2009.
10a Smith, K.D., Fu, M.A., Brown, E.J.: Tim-Tipin dysfunction creates an indispensible reliance on the ATR-Chk1 pathway for continued DNA synthesis. The Journal of Cell Biology 187(1): 15-23, 2009.
16a Ruzankina, Y., Pinzon-Guzman, C., Asare, A., Ong, T., Pontano, L., Cotsarelis, G., Zediak, V.P., Velez, M., Bhandoola, A., Brown, E.J.: Deletion of the developmentally essential gene ATR in adult mice leads to premature aging phenotypes and stem cell loss. Cell Stem Cell 1: 113-126, 2007.
13f Urtishak KA, Smith KD, Chanoux RA, Greenberg RA, Johnson FB, Brown EJ: Timeless maintains genomic stability and suppresses sister chromatid exchange during unperturbed DNA replication. The Journal of Biological Chemistry 284(13): 8777–85, 2009.
2c
7
1d
1f
Selected Publications
1c0 Shastri N, Tsai Y-C, Hile S, Jordan D, Powell B, Chen J, Maloney D, Dose M, Lo Y, Anastassiadis T, Rivera O, Kim T, Shah S, Borole P, Asija K, Wang X, Smith KD, Finn D, Schug J, Casellas R, Yatsunyk LA, Eckert KA and Brown EJ : Genome-wide identification of structure-forming repeats as principal sites of fork collapse upon ATR inhibition. Molecular Cell 72: 222-238, 2018.12b Kim H, George E, Ragland R, Rafial S, Zhang R, Krepler C, Morgan M, Drapkin R, Brown EJ and Simpkins F: Targeting ATR/CHK1 is more effective than PARPi alone in BRCA mutant models. Clinical Cancer Research 23: 3097-3108, 2017.
ad Anastassiadis T, Brown EJ: Wild-type RAS: Keeping mutant RAS in CHK. Cancer Cell 25(2): 137-8, 2014.
110 Ragland RL, Patel S, Rivard RS, Smith K, Peters AA, Bielinsky AK, Brown EJ: RNF4 and PLK1 are required for replication fork collapse in ATR-deficient cells. Genes & Development 27(20): 2259-73, 2013.
13a Schoppy DW, Ragland RL, Gilad O, Shastri N, Peters AA, Murga M, Fernandez-Capetillo O, Diehl JA, Brown EJ: Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR. Journal of Clinical Investigation 122(1): 241-252, 2012.
175 Gilad, O., Nabet, B.L., Ragland, R.L., Schoppy, D.W., Smith, K.D., Durham, A.C., Brown, E.J: Combining ATR suppression with oncogenic Ras synergystically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner. Cancer Research 70(23): 9693-9702, 2010.
12f Ruzankina, Y., Schoppy, D.W., Asare, A., Clark, C.E., Vonderheide, R.H., Brown, E.J.: Tissue regenerative delays and synthetic lethality in adult mice upon combined deletion of ATR and p53. Nature Genetics 41(10): 1144-1149, 2009.
11a Chanoux, R.A., Yin, B., Urtishak, K.A., Bassing, C.H., Brown, E.J.: ATR and H2AX cooperate in maintaining genome stability under replication stress. The Journal of Biological Chemistry 284(9): 5994-6003, 2009.
10a Smith, K.D., Fu, M.A., Brown, E.J.: Tim-Tipin dysfunction creates an indispensible reliance on the ATR-Chk1 pathway for continued DNA synthesis. The Journal of Cell Biology 187(1): 15-23, 2009.
16a Ruzankina, Y., Pinzon-Guzman, C., Asare, A., Ong, T., Pontano, L., Cotsarelis, G., Zediak, V.P., Velez, M., Bhandoola, A., Brown, E.J.: Deletion of the developmentally essential gene ATR in adult mice leads to premature aging phenotypes and stem cell loss. Cell Stem Cell 1: 113-126, 2007.
13f Urtishak KA, Smith KD, Chanoux RA, Greenberg RA, Johnson FB, Brown EJ: Timeless maintains genomic stability and suppresses sister chromatid exchange during unperturbed DNA replication. The Journal of Biological Chemistry 284(13): 8777–85, 2009.
2c